General Announcement::Announcement by TMC Life Sciences Berhad, a subsidiary of Thomson Medical Group Limited

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED GRP LTD W190424 - SG5HB3000007 - CSIW
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
31-Oct-2018 20:34:39
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Berhad, a subsidiary of Thomson Medical Group Limited
Announcement Reference
SG181031OTHR3VEN
Submitted By (Co./ Ind. Name)
Hasan Malik
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
TMC Life Sciences Berhad, a subsidiary of Thomson Medical Group Limited, has made the following announcement on Bursa Malaysia on 31 October 2018:-

TMC LIFE SCIENCES BERHAD

INTRODUCTION

The Company wishes to announce that BB Waterfront Sdn. Bhd. ( BBWF ), a wholly owned subsidiary of the Company had on 29 October 2018 awarded the Piling Works to Putra Perdana Construction Sdn. Bhd. for the Proposed 33-Storey Mixed Development at PTB 24075, Jalan Stulang Darat, Stulang Laut, Bandar Johor Bahru, Daerah Johor Bahru ( the Contract ) to facilitate the construction work on Thomson Iskandar Medical Hub.

CONTRACT PERIOD

The Contract period will be for a period of Forty (40) weeks, commencing on 26 November 2018 and to be completed by or before 2 September 2019.

CONTRACT SUM

The Contract Sum is Ringgit Malaysia Forty Eight Million Six Hundred Ninety-Six Thousand Six Hundred Twenty Eight (RM48,696,628) only.

RISKS

The Board of Directors of the Company does not envisage any specific risk to be associated with the Contract, apart from the operational and financial costs.

FINANCIAL EFFECTS

The Contract will not have any effect on the issued and paid-up share capital of the Company and is not expected to have any material effect on the earnings, earnings per share, net asset value and gearing of TMC Group during the Contract period.

The Contract will be funded through internally-generated funds.

DIRECTORS AND MAJOR SHAREHOLDERS INTEREST

None of the Directors and/or major shareholders of the Company and/or persons connected with them, have any interest, direct or indirect, in the Contract.